Patent application number | Description | Published |
20080261271 | EXPRESSION OF HIV POLYPEPTIDES AND PRODUCTION OF VIRUS-LIKE PARTICLES - The present invention relates to the efficient expression of HIV polypeptides in a variety of cell types, including, but not limited to, mammalian, insect, and plant cells. Synthetic expression cassettes encoding the HIV Gag-containing polypeptides are described, as are uses of the expression cassettes in applications including DNA immunization, generation of packaging cell lines, and production of Env-, tat- or Gag-containing proteins. The invention provides methods of producing Virus-Like Particles (VLPs), as well as, uses of the VLPs including, but not limited to, vehicles for the presentation of antigens and stimulation of immune response in subjects to whom the VLPs are administered. | 10-23-2008 |
20110065146 | Expression of HIV polypeptides and production of virus-like particles - The present invention relates to the efficient expression of HIV polypeptides in a variety of cell types, including, but not limited to, mammalian, insect, and plant cells. Synthetic expression cassettes encoding the HIV Gag-containing polypeptides are described, as are uses of the expression cassettes in applications including DNA immunization, generation of packaging cell lines, and production of Env-, tat- or Gag-containing proteins. The invention provides methods of producing Virus-Like Particles (VLPs), as well as, uses of the VLPs including, but not limited to, vehicles for the presentation of antigens and stimulation of immune response in subjects to whom the VLPs are administered. | 03-17-2011 |
20120269840 | EXPRESSION OF HIV POLYPEPTIDES AND PRODUCTION OF VIRUS-LIKE PARTICLES - The present invention relates to the efficient expression of HIV polypeptides in a variety of cell types, including, but not limited to, mammalian, insect, and plant cells. Synthetic expression cassettes encoding the HIV Gag-containing polypeptides are described, as are uses of the expression cassettes in applications including DNA immunization, generation of packaging cell lines, and production of Env-, tat- or Gag-containing proteins. The invention provides methods of producing Virus-Like Particles (VLPs), as well as, uses of the VLPs including, but not limited to, vehicles for the presentation of antigens and stimulation of immune response in subjects to whom the VLPs are administered. | 10-25-2012 |
Patent application number | Description | Published |
20100113487 | PYRIMIDINONE DERIVATIVES AND METHODS OF USE THEREOF - The present invention relates to Pyrimidinone Derivatives, compositions comprising a Pyrimidinone Derivative, and methods of using the Pyrimidinone Derivatives for treating or preventing obesity, diabetes, a metabolic disease, a cardiovascular disease or a disorder related to the activity of GPR119 in a patient. | 05-06-2010 |
20100190687 | PYRIMIDINONE DERIVATIVES AND METHODS OF USE THEREOF - The present invention relates to Pyrimidinone Derivatives, compositions comprising a Pyrimidinone Derivative, and methods of using the Pyrimidinone Derivatives for treating or preventing obesity, diabetes, a metabolic disorder, a cardiovascular disease or a disorder related to the activity of G protein-coupled receptor 119 (“GPR119”) in a patient. | 07-29-2010 |
20110065671 | BICYCLIC HETEROCYCLE DERIVATIVES AND USE THEREOF AS GPR119 MODULATORS - The present invention relates to Bicyclic Heterocycle Derivatives of formula (I), compositions comprising a Bi-cyclic Heterocycle Derivative, and methods of using the Bicyclic Heterocycle Derivatives for treating or preventing obesity, diabetes, a metabolic disorder, a cardiovascular disease or a disorder related to the activity of GPR1 19 in a patient. | 03-17-2011 |
20110263624 | BICYCLIC HETEROCYCLE DERIVATIVES AND METHODS OF USE THEREOF - The present invention relates to Bicyclic Heterocycle Derivatives, compositions comprising a Bicyclic Heterocycle Derivative, and methods of using the Bicyclic Heterocycle Derivatives for treating or preventing obesity, diabetes, a metabolic disorder, a cardiovascular disease or a disorder related to the activity of a GPCR in a patient. | 10-27-2011 |
20120040975 | BRIDGED BICYCLIC HETEROCYCLE DERIVATIVES AND METHODS OF USE THEREOF - The present invention relates to Bridged Bicyclic Heterocycle Derivatives, compositions comprising a Bridged Bicyclic Heterocycle Derivative, and methods of using the Bridged Bicyclic Heterocycle Derivatives for treating or preventing obesity, diabetes, a metabolic disorder, a cardiovascular disease or a disorder related to the activity of a GPCR in a patient. | 02-16-2012 |
20120232073 | FUSED BICYCLIC PYRIMIDINE DERIVATIVES AND METHODS OF USE THEREOF - The present invention relates to Fused Bicyclic Pyrimidine Derivatives, compositions comprising a Fused Bicyclic Pyrimidine Derivative, and methods of using the Fused Bicyclic Pyrimidine Derivatives for treating or preventing obesity, diabetes, a metabolic disorder, a cardiovascular disease or a disorder related to the activity of a G-protein coupled receptor (GPCR) in a patient. | 09-13-2012 |
20130096141 | BICYCLIC HETEROCYCLE DERIVATIVES AND METHODS OF USE THEREOF - Compounds of structural formula I: are GPR119 agonists and are useful for the treatment, control or prevention of disorders responsive to agonism of GPR119, such as metabolic-related disorders such as type I diabetes, type II diabetes, inadequate glucose tolerance, insulin resistance, hyperglycemia, hyperlipidemia, hypertriglyceridemia, hypercholesterolemia, dyslipidemia or syndrome X. The compounds are also reported as being useful for controlling weight gain, controlling food intake, and inducing satiety in mammals. | 04-18-2013 |
20140199263 | HETEROCYCLIC-SUBSTITUTED BENZOFURAN DERIVATIVES AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES - The present invention relates to compounds of formula (I) that are useful as hepatitis C virus (HCV) NS5B polymerase inhibitors, the synthesis of such compounds, and the use of such compounds for inhibiting HCV NS5B polymerase activity, for treating or preventing HCV infections and for inhibiting HCV viral replication and/or viral production in a cell-based system. | 07-17-2014 |
20140213571 | TETRACYCLIC HETEROCYCLE COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES - The present invention relates to compounds of formula (I) that are useful as hepatitis C virus (HCV) NS5B polymerase inhibitors, the synthesis of such compounds, and the use of such compounds for inhibiting HCV NS5B polymerase activity, for treating or preventing HCV infections and for inhibiting HCV viral replication and/or viral production in a cell-based system. | 07-31-2014 |
20150246902 | SUBSTITUED BENZOFURAN COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES - The present invention relates to compounds of formula (I) that are useful as hepatitis C virus (HCV) NS5B polymerase inhibitors, the synthesis of such compounds, and the use of such compounds for inhibiting HCV NS5B polymerase activity, for treating or preventing HCV infections and for inhibiting HCV viral replication and/or viral production in a cell-based system. | 09-03-2015 |
20150361101 | TETRACYCLIC HETEROCYCLE COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF HEPATITIS C - The present invention relates to compounds of formula I that are useful as hepatitis C virus (HCV) NS5B polymerase inhibitors, the synthesis of such compounds, and the use of such compounds for inhibiting HCV NS5B polymerase activity, for treating or preventing HCV infections and for inhibiting HCV viral replication and/or viral production in a cell-based system. | 12-17-2015 |
20150368246 | TETRACYCLIC HETEROCYCLE COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF HEPATITIS C - The present invention relates to compounds of formula I that are useful as hepatitis C virus (HCV) NS5B polymerase inhibitors, the synthesis of such compounds, and the use of such compounds for inhibiting HCV NS5B polymerase activity, for treating or preventing HCV infections and for inhibiting HCV viral replication and/or viral production in a cell-based system. I | 12-24-2015 |
20160130259 | SUBSTITUTED BENZOFURAN COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES - The present invention relates to compounds of formula I that are useful as hepatitis C virus (HCV) NS5B polymerase inhibitors, the synthesis of such compounds, and the use of such compounds for inhibiting HCV NS5B polymerase activity, for treating or preventing HCV infections and for inhibiting HCV viral replication and/or viral production in a cell-based system. | 05-12-2016 |
20160136172 | SUBSTITUTED BENZOFURAN COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES - The present invention relates to compounds of formula I that are useful as hepatitis C virus (HCV) NS5B polymerase inhibitors, the synthesis of such compounds, and the use of such compounds for inhibiting HCV NS5B polymerase activity, for treating or preventing HCV infections and for inhibiting HCV viral replication and/or viral production in a cell-based system. | 05-19-2016 |
Patent application number | Description | Published |
20090088037 | LAMINATED FABRIC CONSTRUCTION WITH POLYOLEFIN COMPOSITIONS - Articles comprising multiple layers are included. The multiple layer articles may include fabrics, foams, films, fiber in combination with a polyolefin composition such as a film, powder, or nonwoven. | 04-02-2009 |
20100063218 | NON-TEXTILE POLYMER COMPOSITIONS AND METHODS - Included are nylon and polyurethane urea compositions such as in the form of powders, beads and flock to be included in extruded and molded articles containing a thermoplastic resin such as nylon 12. The addition of the powders, beads or flock improve flexibility and shape retention of such molded articles, for example in eyewear frames. | 03-11-2010 |
20110059143 | NON-TEXTILE POLYMER COMPOSITIONS AND METHODS - Included are polymer compositions such as polyurethaneureas, polyamides and polyesters. The compositions may be in a variety of forms such as dispersions, powders, fibers, and beads. The compositions are useful in the preparation of many products including health and beauty products such as cosmetics, paint, household products such as fabric care compositions, apparel/footwear and textiles/furnishings. | 03-10-2011 |
20110151233 | FABRIC INCLUDING POLYOLEFIN ELASTIC FIBER - An article comprising a yarn comprising an elastomeric propylene-based polymer composition; said polymer composition comprising at least one elastomeric propylene-based polymer, wherein said yarn has a draft greater than 200%; wherein said article is a fabric or a garment. | 06-23-2011 |
20110152462 | POLYOLEFIN ELASTIC FIBER - An article comprising a yarn comprising an elastomeric propylene-based polymer composition; said polymer composition comprising at least one elastomeric propylene-based polymer, wherein said yarn has break elongation of greater than 200%. | 06-23-2011 |
20110152810 | ELASTIC FIBER CONTAINING AN ANTI-TACK ADDITIVE - Embodiments of the disclosure include elastomeric stretch fibers containing an anti-tack agent, methods of preparing the fiber, methods of using this fiber, articles including this fiber, and the like. | 06-23-2011 |
20110201734 | AQUEOUS POLYURETHANUREA COMPOSITIONS INCLUDING DISPERSIONS AND FILMS - Included are polyurethaneurea compositions include polyurethaneurea aqueous dispersions. The dispersions may be prepared with solvent or in the absence of any added solvent. Films and other shaped articles may be prepared from the dispersions by a casting a drying method and optionally included with a substrate including paper, fabric or garments. The films exhibit a reduced discoloring or yellowing upon exposure to atmosphere, heat, and UV. | 08-18-2011 |
20110275265 | BICOMPONENT SPANDEX - An elastic multiple component fiber comprising a cross-section, wherein at least a first region of said cross-section comprises a polyurethaneurea composition; and comprising a second region. | 11-10-2011 |
20110283435 | FUSIBLE BICOMPONENT SPANDEX - Included are multiple component elastic fibers prepared by a solution-spinning process such as dry spinning or wet spinner of spandex fibers including polyurethaneurea and polyurethane compositions. These fibers have a cross-section including at least two separate regions with definable boundaries wherein at least one region defined by the boundaries of the cross-section includes a polyurethaneurea or polyurethane composition. One region of the fiber includes a fusibility improvement additive to enhance adhesion to itself or to a substrate. | 11-24-2011 |
20120034834 | FUSIBLE BICOMPONENT SPANDEX - Included are multiple component elastic fibers prepared by a solution-spinning process such as dry spinning or wet spinner of spandex fibers including polyurethaneurea and polyurethane compositions. These fibers have a cross-section including at least two separate regions with definable boundaries wherein at least one region defined by the boundaries of the cross-section includes a polyurethaneurea or polyurethane composition. One region of the fiber includes a fusibility improvement additive to enhance adhesion to itself or to a substrate. | 02-09-2012 |
20120259074 | POLYURETHANE ELASTIC YARN AND PRODUCTION METHOD THEREOF - [Problem] To provide a polyurethane elastic yarn which has the high strength and ductility sought in polyurethane elastic yarn, and also has excellent durability and heat resistance, as well as little fatigue at low temperature; and a production method thereof. | 10-11-2012 |
20130022796 | ELASTIC FABRIC WITH ADHESIVE - Included are elastic laminate articles that include multiple layers. This includes one stretch fabric comprising about 50% to 100% elastic fibers by weight of the fabric, including fabrics that include 100% elastic fibers and at least one adhesive. | 01-24-2013 |
20130302574 | SOLVENT FREE AQUEOUS POLYURETHANE DISPERSIONS AND SHAPED ARTICLES THEREFROM - Novel aqueous polyurethane dispersions and shaped three dimensional articles formed therefrom are provided. The aqueous polyurethane dispersions are provided in solvent-free systems of a prepolymer comprising at least one polyether, polyester, or polycarbonate polyol, a mixture of MDI isomers, and a diol. The shaped articles from such dispersions can be heat-activated for bonding, lamination, and adhesion of substrates, including stretch fabrics. | 11-14-2013 |
20140087170 | ELASTIC FABRIC - To provide elastic fabric that has comfortable wear and fit even in thin and light fabric by using a high-powered polyurethane elastic fiber that has at least 1.5 times the active force and recovery per unit fineness at the time of 100 to 200% elongation compared to conventional polyurethane elastic fiber. Resolution means an elastic fabric comprising a polyurethane elastic fiber made of a polyol, with a molecular weight between 450 and 1600 with a ratio of weight average molecular weight to number average molecular weight of at least 1.8, an organic diisocyanate compound, and a diamine compound. | 03-27-2014 |
20140103555 | POLYOLEFIN ELASTIC FIBER - An article comprising a yarn comprising an elastomeric propylene-based polymer composition; said polymer composition comprising at least one elastomeric propylene-based polymer, wherein said yarn has break elongation of greater than 200%. | 04-17-2014 |
20140217648 | FABRIC INCLUDING POLYOLEFIN ELASTIC FIBER - An article comprising a yarn comprising an elastomeric propylene-based polymer composition; said polymer composition comprising at least one elastomeric propylene-based polymer, wherein said yarn has a draft greater than 200%; wherein said article is a fabric or a garment. | 08-07-2014 |
20140357730 | NON-TEXTILE POLYMER COMPOSITIONS AND METHODS - Included are polymer compositions such as polyurethaneureas, polyamides and polyesters. The compositions may be in a variety of forms such as dispersions, powders, fibers, and beads. The compositions are useful in the preparation of many products including health and beauty products such as cosmetics, paint, household products such as fabric care compositions, apparel/footwear and textiles/furnishings. | 12-04-2014 |
20150079339 | LAMINATED FABRIC CONSTRUCTION WITH HEAT ACTIVATED POLYURETHANEUREA COMPOSITIONS - Articles comprising multiple layers are included. The multiple layer articles may include fabrics or foams in combination with a polyurethaneurea composition such as a film or an aqueous dispersion. | 03-19-2015 |
20160122907 | FUSIBLE BICOMPONENT SPANDEX - Included are segmented polyurethane elastic fibers or spandex fibers, capable of bonding to polymer fiber such as nylon or polyamide fibers, in addition to bonding to itself, for apparel textile applications. More particularly the invention relates to bicomponent spandex fibers, with a heat resistant core and a heat sensitive sheath, spun from polymer solutions. The nylon fabrics containing such spandex fibers have enhanced stretch performance and improved surface appearance after heat treatment to activate the fusing and bonding between nylon fibers and spandex fibers. | 05-05-2016 |
Patent application number | Description | Published |
20080242671 | INHIBITORS OF CATHEPSIN S - The present invention provides compounds, compositions and methods for the selective inhibition of cathepsin S. In a preferred aspect, cathepsin S is selectively inhibited in the presence of at least one other cathepsin isozyme. The present invention also provides methods for treating a disease state in a subject by selectively inhibiting cathepsin S. | 10-02-2008 |
20090137570 | INHIBITORS OF CATHEPSIN S - The present invention provides compounds, compositions and methods for the selective inhibition of cathepsin S. In a preferred aspect, cathepsin S is selectively inhibited in the presence of at least one other cathepsin isozyme. The present invention also provides methods for treating a disease state in a subject by selectively inhibiting cathepsin S. | 05-28-2009 |
20090247517 | COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF CANNABINOID RECEPTOR 1 ACTIVITY - The invention provides compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with the activity of Cannabinoid Receptor 1 (CB1). | 10-01-2009 |
20090247556 | Azolopyrimidines as Inhibitors of Cannabinoid 1 Activity - The invention provides compounds of formula (Ia), (Ic), (Ig) and (Ik), pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with the activity of Cannabinoid Receptor 1 (CB1). | 10-01-2009 |
20100204200 | INHIBITORS OF CATHEPSIN S - The present invention provides compounds, compositions and methods for the selective inhibition of cathepsin S. In a preferred aspect, cathepsin S is selectively inhibited in the presence of at least one other cathepsin isozyme. The present invention also provides methods for treating a disease state in a subject by selectively inhibiting cathepsin S. More particularly, the present invention provides compounds having Formula 1: | 08-12-2010 |
20100234365 | COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF CANNABINOID RECEPTOR 1 ACTIVITY - The invention provides compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with the activity of Cannabinoid Receptor 1 (CB1). | 09-16-2010 |
20110053897 | COMPOUNDS AND COMPOSITIONS AS SYK KINASE INHIBITORS - Provided herein area novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated Syk kinase activity. | 03-03-2011 |
20110172278 | COMPOUNDS AND METHODS FOR MODULATING G PROTEIN-COUPLED RECEPTORS - The invention provides compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with or mediated by G protein-coupled receptors, in particular G protein-coupled receptor 120. | 07-14-2011 |
20110245243 | COMPOUNDS AND COMPOSITIONS AS CATHEPSIN S INHIBITORS - The invention provides compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with the activity of Cathepsin S. | 10-06-2011 |
20120184526 | COMPOUNDS AND COMPOSITIONS AS SYK KINASE INHIBITORS - Provided herein are a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated Syk kinase activity. | 07-19-2012 |
20120225869 | COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF CANNABINOID RECEPTOR 1 ACTIVITY - The invention provides compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with the activity of Cannabinoid Receptor 1 (CB1). | 09-06-2012 |
20130096165 | COMPOUNDS AND METHODS FOR MODULATING G PROTEIN-COUPLED RECEPTORS - The invention provides compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with or mediated by G protein-coupled receptors, in particular G protein-coupled receptor 120. | 04-18-2013 |
20130210769 | COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF CANNABINOID RECEPTOR 1 ACTIVITY - The invention provides compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with the activity of Cannabinoid Receptor 1 (CB1). | 08-15-2013 |
Patent application number | Description | Published |
20100025031 | MULTIPLE TANKS WATER THERMAL STORAGE SYSTEM AND ITS USING METHOD - A multiple-tank water thermal storage system and its using method belong to energy saving technology. The multiple-tank water thermal storage system includes at least two water tanks. There are an upper diffuser ( | 02-04-2010 |
20100303009 | METHOD AND SYSTEM FOR SELECTING ACCESS GATEWAY AND GATEWAY SELECTION EXECUTION NODE IN MOBILE PACKET DOMAIN - A method and system for selecting a gateway and a gateway selection execution node in the mobile packet domain are disclosed. The method includes: encapsulating, by a gateway selection execution node upon reception of a bearer setup request transmitted from a User Equipment, an operator domain name corresponding to the bearer setup request into a DNS parse request when creating the DNS parse request, and transmitting the DNS parse request to a DNS server; parsing by the DNS server for obtaining the address of an access gateway; returning by the DNS server, to the gateway selection execution node, a DNS parse result containing the address information of the access gateway corresponding to the operator domain name; selecting by the gateway selection execution node according to the address information the access gateway corresponding to the operator domain name as the access gateway corresponding to the bearer setup request. | 12-02-2010 |
20140360266 | NOVEL BELL-SHAPED VIBRATOR TYPE ANGULAR RATE GYRO - The present invention provides an angular rate gyro in which a bell-shaped vibrator having nonuniform thickness, axially symmetric and multi curved surface combined structural features is used as a sensitive element. The angular rate gyro is composed of the bell-shaped vibrator, a vibrator fixing shaft, a vibrator base, an airtight hood, a housing and a circuit system. The bell-shaped vibrator includes a bell shoulder having a hemispheric shell structure, a bell waist having a cylindrical shell structure and a bell lip having a hyperboloidal shell structure. The bell-shaped vibrator, the base and a central shaft are mechanically and fixedly connected together to be formed into an integral core having sensitive gyratory effect. A circuit system is used to control vibration forms of the bell-shaped vibrator, perform signal processing and solve the applied angular rate. | 12-11-2014 |
20150323413 | Tap-Scan Bridge Damage Detection System - A tap-scan bridge damage detection system comprises: a mobile cart ( | 11-12-2015 |
Patent application number | Description | Published |
20100120870 | Dispersible pesticidal compositions - Soluble granule pesticidal compositions comprise Flonicamid, a dispersant, and a wetting agent are disclosed. | 05-13-2010 |
20100197739 | Stable Suspension Concentrate Formulation for Water-Soluble Compounds - The present invention is directed to an insecticidal water based suspension concentrate formulation comprising a water-soluble insecticide selected from the group consisting of N-cyanomethyl-4-(trifluoromethyl)nicotinamide and (EZ)-1-(6-chloro-3-pyridylmethyl)-N-nitroimidazolidin-2-ylidineamine and at least one water-soluble salt selected from the group consisting of magnesium sulfate (hydrated and anhydrous forms) and sodium sulfate, wherein the water-soluble insecticide is present in an insecticidally effective amount and methods of use. | 08-05-2010 |
20100234225 | Stable Mixtures of Microencapsulated and Non-Encapsulated Pesticides - The present invention is directed to a composition comprising i) a microencapsulated pesticide, ii) a dispersant selected from the group consisting of a lignin, b) a lignosulfonate salt and c) a lignosulfonate salt combined with the sodium salt of substituted naphthalene sulfonate formaldehyde polymer, iii) a salt selected from the group consisting of magnesium sulfate, sodium chloride, sodium nitrate and calcium chloride, and iv) a non-encapsulated pesticide. The present invention is also directed to methods of making and using the compositions of the present invention. | 09-16-2010 |
20120190547 | Herbicidal Composition in Granular Form - The present invention provides light weight, water dispersible, granular compositions containing a first herbicide and a second herbicide in which the first herbicide and the second herbicide have different physical characteristics. In particular, the present invention relates to granular herbicidal compositions comprising a low melting point herbicide, carfentrazone-ethyl, and a high melting point herbicide, sulfosulfuron, having excellent dispersibility in water and chemical and physical stability. | 07-26-2012 |
20140031231 | FORMULATIONS OF CLOMAZONE - New formulations of clomazone are provided, as well as new methods for making formulations of clomazone. The new formulations provide improved efficacy, decreased volatility, and/or increased loading of clomazone over the clomazone formulations in the prior art. | 01-30-2014 |
20160128330 | Stable Suspension Concentrate Formulation for Water-Soluble Compounds - The present invention is directed to an insecticidal water based suspension concentrate formulation comprising a water-soluble insecticide selected from the group consisting of N-cyanomethyl-4-(trifluoromethyl)nicotinamide and (EZ)-1-(6-chloro-3-pyridylmethyl)-N-nitroimidazolidin-2-ylidineamine and at least one water-soluble salt selected from the group consisting of magnesium sulfate (hydrated and anhydrous forms) and sodium sulfate, wherein the water-soluble insecticide is present in an insecticidally effective amount and methods of use. | 05-12-2016 |
20160135462 | FORMULATIONS OF CLOMAZONE - New formulations of clomazone are provided, as well as new methods for making formulations of clomazone. The new formulations provide improved efficacy, decreased volatility, and/or increased loading of clomazone over the clomazone formulations in the prior art. | 05-19-2016 |
Patent application number | Description | Published |
20100023776 | Method and System for Storing a Key in a Remote Security Module - The invention concerns a method for obtaining assurance that a content control key is securely stored in a remote security module for further secure communications between a content provider and said security. A security module manufacturer, which has a pre-established trustful relation with the security module, imports a symmetric transport key into the security module, wherein the symmetric transport key is unique to the security module. The content provider shares the symmetric transport key with the security module manufacturer and exchanges messages with the security module through a security module communication manager in order to get the proof that the security module stores the content control key. At least a portion of the messages exchanged between the content provider and the security module are protected using the symmetric transport key. | 01-28-2010 |
20110116093 | SENSOR CHIP FOR BIOLOGICAL AND CHEMICAL SENSING - A sensor chip comprising:
| 05-19-2011 |
20130208254 | NANO-PHOTOLITHOGRAPHIC SUPERLENS DEVICE AND METHOD FOR FABRICATING SAME - A system for nano-photolithography, a superlens device, and a method for fabricating the superlens device. A system for three-dimensional nano-photolithography includes a light source having a predetermined light wavelength, a device to be patterned, a photoresist layer of photoresponsive material photoresponsive to the predetermined light wavelength formed on the device, and a superlens device in contact with the photoresist layer. The superlens device includes a superlens layer in contact with the photoresist layer, a light permissive mask layer transparent to the predetermined light wavelength and having a layer of nanopatterned opaque features formed thereon, and an intermediate layer separating the superlens layer and the light permissive mask layer by a predetermined distance. The light source is located to radiate light at the predetermined light wavelength on the light permissive mask layer. The layer of nanopatterned opaque features includes a layer of opaque features with varying height dimensions. | 08-15-2013 |
20140095879 | STORING A KEY IN A REMOTE SECURITY MODULE - A system obtains assurance by a content provider that a content control key is securely stored in a remote security module for further secure communications between the content provider and the security module. A security module manufacturer, which has a pre-established trustful relation with the security module, imports a symmetric transport key into the security module. The symmetric transport key is unique to the security module. The content provider shares the symmetric transport key with the security module manufacturer. The content provider exchanging messages with the security module through a security module communication manager in order to get the proof that the security module stores the content control key. At least a portion of the messages exchanged between the content provider and the security module are protected using the symmetric transport key. The symmetric transport key is independent of said content control key. | 04-03-2014 |
20160043864 | STORING A KEY IN A REMOTE SECURITY MODULE - A system obtains assurance by a content provider that a content control key is securely stored in a remote security module for further secure communications between the content provider and the security module. A security module manufacturer, which has a pre-established trustful relation with the security module, imports a symmetric transport key into the security module. The symmetric transport key is unique to the security module. The content provider shares the symmetric transport key with the security module manufacturer. The content provider exchanging messages with the security module through a security module communication manager in order to get the proof that the security module stores the content control key. At least a portion of the messages exchanged between the content provider and the security module are protected using the symmetric transport key. The symmetric transport key is independent of said content control key. | 02-11-2016 |
Patent application number | Description | Published |
20090190934 | FIBER COMMUNICATION SYSTEM, FIBER AMPLIFIER, AND METHOD FOR FABRICATING FIBER AMPLIFIER - The present invention discloses a fiber amplifier, a fabricating method thereof, and a fiber communication system. The fiber amplifier includes at least a pump laser, at least a gain medium and at least an integrated optical component. The integrated optical component includes multiple optical input/output ports, and the optical input/output ports are connected to the pump laser or gain medium directly or indirectly. The present invention may better address problems of unstable performance and difficulty in reducing the size of components in the prior art where fiber amplifiers are formed by a number of discrete components with many fiber fusion splices. In addition, the present invention may reduce the production complexity and costs of fiber amplifiers, and improve the productivity of fiber amplifiers. | 07-30-2009 |
20100005660 | METHOD OF MANUFACTURING SUSPENSION SUPPORT DEVICES - A method of manufacturing suspension devices comprising the steps of:
| 01-14-2010 |
20120057876 | METHOD FOR AMPLIFYING A BURST OPTICAL SIGNAL, BURST OPTICAL AMPLIFIER AND SYSTEM, AND COMMUNICATIONS SYSTEM - A method for amplifying a burst optical signal, a burst optical amplifier and system, and a communications system are provided according to embodiments of the present invention. The method includes: combining an auxiliary light and a signal light into a mixed light and outputting the mixed light, where the auxiliary light is a non-burst light, the signal light is a burst light, and power of the auxiliary light is set to be independent from power of the signal light; generating a pump light; and combining the pump light with the mixed light and inputting the combined light into a gain medium, so as to obtain an amplified mixed light. Present invention has the following advantages: reducing the delay time of enabling the burst optical amplifier, improving the transient response speed of the burst optical amplifier, and preventing the generation of a surge phenomenon, so as to prevent the generation of signal distortion. | 03-08-2012 |
20120243076 | METHOD, APPARATUS, AND SYSTEM FOR AMPLIFYING A BURST OPTICAL SIGNAL - Embodiments of the present invention disclose a method, an apparatus, and a system for amplifying a burst optical signal. The method includes: monitoring an input status of a signal light; when no signal light is input, controlling output power of a pump light so that a gain medium has output optical power and the output optical power is less than a maximum optical power that the gain medium is capable of outputting when a signal light is input; inputting the pump light into a wavelength division multiplexer so that the wavelength division multiplexer combines the signal light and the pump light and inputs the combined light into the gain medium. With the preceding manners, when no signal light is input, the power of the pump light is controlled. | 09-27-2012 |
20140355751 | Systems and Methods for Echo Reduction - Systems and methods are provided for echo reduction. For example, first audio data associated with a current time unit is obtained, the first audio data being generated by an audio-acquisition device of a receiver based on at least information associated with a first audio signal acquired by the audio-acquisition device and a second audio signal output from an audio-playback device of the receiver, the second audio signal being output from the audio-playback device of the receiver based on at least information associated with second audio data transmitted previously by a sender before the current time unit; third audio data transmitted by the sender during a second time unit preceding the current time unit is obtained; and fourth audio data is obtained by performing echo reduction on the first audio data based on at least information associated with the third audio data. | 12-04-2014 |
20140358264 | AUDIO PLAYBACK METHOD, APPARATUS AND SYSTEM - An audio playback method is provided. The method includes identifying a captured audio data frame according to a type of the audio data frame and sending the identified audio data frame to an audio receiving end. The method also includes receiving the audio data frame that is identified according to the type of the audio data frame and determining the type of the audio data frame and evaluating network transmission status based on the identification. Further, the method includes adjusting a threshold value of a jitter buffer that is used to cache the audio data frame when the type of the audio data frame is a music frame and evaluation result of the network transmission status does not meet a preset transmission baseline condition. | 12-04-2014 |
20150112668 | VOICE PROCESSING METHOD, APPARATUS, AND SYSTEM - Methods, apparatus, and systems for voice processing are provided herein. An exemplary method can be implemented by a terminal. A voice bit stream to be sent can be obtained. Voice control information corresponding to the voice bit stream to be sent can be obtained. The voice control information can be used for a voice server to determine a voice-mixing strategy. The voice bit stream and the voice control information can be sent to the voice server. At least one voice bit stream, returned by the voice server based on the voice-mixing strategy, can be received. The at least one voice bit stream can be outputted. | 04-23-2015 |
20150127356 | METHOD, TERMINAL, SYSTEM FOR AUDIO ENCODING/DECODING/CODEC - Audio encoding methods/terminals, audio decoding methods/terminals, and audio codec systems are provided. A plurality of audio signals that are continuous is obtained. It is determined whether each audio signal of the plurality of audio signals includes a designated signal type, according to an audio parameter of each audio signal. A marked audio encoding stream is obtained by performing a marking to each audio signal as having or not having the designated signal type. The marking is used, at a decoding terminal, to perform an enhancement-process to one or more audio signals having the designated signal type. The enhancement-process is not performed to audio signals that do not have the designated signal type. | 05-07-2015 |
20150340046 | Systems and Methods for Audio Encoding and Decoding - Systems and methods are provided for audio encoding. For example, first quantization encoding is performed on audio data associated with a current frame of an audio data stream to obtain first quantization-encoded data; second quantization encoding is performed on the audio data to obtain second quantization-encoded data; the first quantization-encoded data is coupled to the current frame of the audio data stream; and the second quantization-encoded data is coupled to a next frame of the audio data stream. | 11-26-2015 |
Patent application number | Description | Published |
20110292953 | Tunable Multi-Wavelength Semiconductor Laser Array For Optical Communications Based On Wavelength Division Multiplexing - Techniques, devices and systems for optical communications based on wavelength division multiplexing (WDM) that use tunable multi-wavelength laser transmitter modules. | 12-01-2011 |
20110293279 | Tunable Multi-Wavelength Optical Transmitter and Transceiver for Optical Communications Based on Wavelength Division Multiplexing - Techniques, devices and systems for optical communications based on wavelength division multiplexing (WDM) that use tunable multi-wavelength laser transmitter modules. | 12-01-2011 |
20120269512 | TRANSPORT OF MULTIPLE ASYNCHRONOUS DATA STREAMS USING HIGHER ORDER MODULATION - Aspects of the invention provide transmitters and receivers for managing multiple optical signals. High order modulation, such as phase and/or amplitude modulation, is used to achieve multiple bits per symbol by transporting multiple asynchronous data streams in an optical transport system. One or more supplemental multiplexing techniques such as time division multiplexing, polarization multiplexing and sub-carrier multiplexing may be used in conjunction with the high order modulation processing. This may be done in various combinations to realize a highly spectrally efficient multi-data stream transport mechanism. The system receives a number of asynchronous signals which are unframed and synchronized, and then reframed and tagged prior to the high order modulation. Differential encoding may also be performed. Upon reception of the multiplexed optical signal, the receiver circuitry may employ either direct detection without a local oscillator or coherent detection with a local oscillator. | 10-25-2012 |
20130039656 | MIGRATABLE WAVELENGTH DIVISION MULTIPLEXING PASSIVE OPTICAL NETWORK - A hybrid passive optical network (“PON”) includes a time-division multiplexing (“TDM”) optical line terminal (“OLT”) and a wavelength-division multiplexing (“WDM”) OLT. The TDM OLT communicates with a first group of customer premises (“CPs”) via TDM signals while the WDM OLT communicates with a second group of CPs via WDM signals. A remote node power splitter is coupled to receive the TDM and WDM signals and broadcast both the TDM signals and the WDM signals on all of its ports facing towards the CPs. Optical filters are disposed between the remote node power splitter and the second group of CPs. Each optical filter is configured to pass a sub-group of the WDM signals while blocking other WDM signals such that each of the second group of CPs receives its own allocation of WDM signals but does not receive WDM signals allocated to other CPs of the second group of CPs. | 02-14-2013 |
20130129350 | SERVICE AND APPLICATION LAYER OPTIMIZATION USING VARIABLE RATE OPTICAL TRANSMISSION - Apparatus and methods are provided for application layer optimization in a modern data network. The optimization incorporates variable rate transmission across one or more optical data channels. Data throughput is maximized by enabling quality of service profiles on a per transmission channel basis. According to one aspect, a system is provided in which the application layer is aware of and controls the underlying transmission rate and quality of the transmission. This enables the system to fully utilize the transmission capacity of the channel. The application layer may map different applications to different transmission classes of service. The services can be classified based on data throughput rate, guaranteed error rates, latency and cost, among other criteria. This provides flexibility to the application layer to map some loss tolerant applications to a lower cost (per bit) transmission class. | 05-23-2013 |
20130315269 | TUNABLE MULTI-WAVELENGTH SEMICONDUCTOR LASER ARRAY FOR OPTICAL COMMUNICATIONS BASED ON WAVELENGTH DIVISION MULTIPLEXING - Techniques, devices and systems for optical communications based on wavelength division multiplexing (WDM) that use tunable multi-wavelength laser transmitter modules. | 11-28-2013 |
20130315599 | TUNABLE MULTI-WAVELENGTH OPTICAL TRANSMITTER AND TRANSCEIVER FOR OPTICAL COMMUNICATIONS BASED ON WAVELENGTH DIVISION MULTIPLEXING - Techniques, devices and systems for optical communications based on wavelength division multiplexing (WDM) that use tunable multi-wavelength laser transmitter modules. | 11-28-2013 |
20140219655 | TRANSPORT OF MULTIPLE ASYNCHRONOUS DATA STREAMS USING HIGHER ORDER MODULATION - Aspects of the invention provide transmitters and receivers for managing multiple optical signals. High order modulation, such as phase and/or amplitude modulation, is used to achieve multiple bits per symbol by transporting multiple asynchronous data streams in an optical transport system. One or more supplemental multiplexing techniques such as time division multiplexing, polarization multiplexing and sub-carrier multiplexing may be used in conjunction with the high order modulation processing. This may be done in various combinations to realize a highly spectrally efficient multi-data stream transport mechanism. The system receives a number of asynchronous signals which are unframed and synchronized, and then reframed and tagged prior to the high order modulation. Differential encoding may also be performed. Upon reception of the multiplexed optical signal, the receiver circuitry may employ either direct detection without a local oscillator or coherent detection with a local oscillator. | 08-07-2014 |
20150222969 | SYSTEMS AND METHODS FOR INCREASING BANDWIDTH IN A COMPUTER NETWORK - Systems and methods for increasing bandwidth in a computer network are provided. A computer network can include a first lower level switch having a first port and a second port. The computer network can include a second lower level switch having a first port and a second port. The computer network can include an upper level switch having respective ports directly coupled to ports of the first and second lower level switches. A third port of the upper level switch can couple to a first port of a passive optical splitter. The passive optical splitter can have second and third ports coupled to respective ports of the first and second lower level switches. The passive optical splitter can be configured to transmit signals received at its first port as output signals on both of its second and third ports. | 08-06-2015 |
20160080103 | SERVICE AND APPLICATION LAYER OPTIMIZATION USING VARIABLE RATE OPTICAL TRANSMISSION - Apparatus and methods are provided for application layer optimization in a modem data network. The optimization incorporates variable rate transmission across one or more optical data channels. Data throughput is maximized by enabling quality of service profiles on a per transmission channel basis. According to one aspect, a system is provided in which the application layer is aware of and controls the underlying transmission rate and quality of the transmission. This enables the system to fully utilize the transmission capacity of the channel. The application layer may map different applications to different transmission classes of service. The services can be classified based on data throughput rate, guaranteed error rates, latency and cost, among other criteria. This provides flexibility to the application layer to map some loss tolerant applications to a lower cost (per bit) transmission class. | 03-17-2016 |
20160119696 | SYSTEMS AND METHODS FOR INCREASING BANDWIDTH IN A COMPUTER NETWORK - Systems and methods for increasing bandwidth in a computer network are provided. A computer network can include a first lower level switch, first and second upper level switches, and first and second passive optical splitters, and a mirror. The first passive optical splitter can have a first port directly coupled to the first upper level switch, a second port directly coupled to the second upper level switch. The second passive optical splitter can have a port directly coupled to a port of the first passive optical splitter, and a port directly coupled to the first lower level switch. The mirror can be coupled to a port of the second passive optical splitter and reflect an optical signal received from the second passive optical splitter to the first upper level switch and second upper level switch through the second passive optical splitter and the first passive optical splitter. | 04-28-2016 |
Patent application number | Description | Published |
20140088130 | HEXAHYDRODIBENZO[A,G]QUINOLIZINE COMPOUND, PREPARATION METHOD THEREOF, PHARMACEUTICAL COMPOSITION AND USE THEREOF - The present invention relates to a novel hexahydrodibenzo[a,g]quinoline compound represented by general formula (I) and its derivatives, enantiomer, diastereoisomer, raceme and mixtures thereof, as well as pharmaceutically acceptable salts thereof. The present invention further relates to a method for preparing the compound, and the compound has good prevention and treatment effect on neurological diseases, especially diseases associated with dopamine receptor and 5-hydroxytryptamine receptor. The bioactivity experiment demonstrates that, the compound is expected to be developed into a novel and potent chemical entity for treating diseases associated with dopamine receptor and 5-hydroxytryptamine receptor, especially schizophrenia, Parkinson's disease, drug addiction, migraine and so on. | 03-27-2014 |
20140323466 | THIENYL [3,2-D] PYRIMIDIN-4-ONE COMPOUNDS, PREPARATION METHOD, PHARMACEUTICAL COMPOSITIONS AND USE THEREOF - Disclosed are new thienyl[3,2-d]pyrimidin-4-one compounds shown as the general formula (I), preparation method, pharmaceutical compositions and pharmacological use thereof. The compounds are strong DPPIV (dipeptide peptidase IV) inhibitors and can treat type II diabetes through well inhibiting DPPIV indirectly increasing the content of GLP-1 in vivo and inducing a series of physiological actions in vivo. Therefore, the compounds could be developed as new promising drugs for treating diabetes. | 10-30-2014 |
20150210711 | HEXAHYDRODIBENZO[A,G]QUINOLIZINE COMPOUND, PREPARATION METHOD THEREOF, PHARMACEUTICAL COMPOSITION AND USE THEREOF - The present invention relates to a novel hexahydrodibenzo[a,g]quinoline compound represented by general formula (I) and its derivatives, enantiomer, diastereoisomer, raceme and mixtures thereof, as well as pharmaceutically acceptable salts thereof. The present invention further relates to a method for preparing the compound, and the compound has good prevention and treatment effect on neurological diseases, especially diseases associated with dopamine receptor and 5-hydroxytryptamine receptor. The bioactivity experiment demonstrates that, the compound is expected to be developed into a novel and potent chemical entity for treating diseases associated with dopamine receptor and 5-hydroxytryptamine receptor, especially schizophrenia, Parkinson's disease, drug addiction, migraine and so on. | 07-30-2015 |
20150284331 | FLUORINE SUBSTITUTED CYCLIC AMINE COMPOUNDS AND PREPARATION METHODS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF - The present invention relates to the field of pharmaceutical chemistry and pharmacotherapeutics, and in particular to compounds of general formula I, racemates, R-isomers, S-isomers, and pharmaceutically acceptable salts thereof and their mixtures, and the preparation methods thereof and a pharmaceutical composition containing the compounds and uses thereof as an acetylcholine esterase inhibitor. | 10-08-2015 |
20160074373 | METHODS AND COMPOSITIONS FOR INHIBITING HUMAN COPPER TRAFFICKING PROTEINS ATOX1 AND CCS - Compositions and methods concern organic molecules that bind to human Atox1 and CCS at the copper trafficking interface of these proteins. This binding suppresses copper trafficking, which leads to inhibition of cancer cell proliferation and tumor growth. In addition to serving as an effective treatment of cancer, these organic molecules inhibit cellular copper uptake and can be used as treatment of disorders of copper metabolism such as Wilson's disease, which is characterized by copper overload, as well as wound healing. | 03-17-2016 |